DuraSeal Sealant Post Market Study
Completed · Not applicable
Conditions studied: Elective Cranial Procedures With Dural Incision
In brief
DuraSeal Dural Sealant has been approved as a dural sealant by the FDA for use in cranial and spinal procedures. This study was completed to further evaluate the safety of the DuraSeal Sealant in a post-approval setting as compared to control (defined as methods typically employed by surgeons to seal the dura).
Key facts
- Study ID
- NCT00704340
- Run by
- Integra LifeSciences Corporation
- People needed
- 237
- Starts
- 2005-09-01
- Expected to finish
- 2009-05-01
- Last updated by the study team
- 2017-09-07
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patient is between 18 and 75 years of age
- Patient is scheduled for an elective cranial procedure that entails a dural incision
- Evidence of intraoperative non-watertight closure
Where it is running
- Confluent Surgical — Waltham, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.